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Abstract
Introduction: To assess the prevalence of dysnatremia, including borderline changes in serum sodium
concentration, and to estimate the impact of these dysnatremia on mortality after adjustment for confounders.
Methods: Observational study on a prospective database fed by 13 intensive care units (ICUs). Unselected patients
with ICU stay longer than 48 h were enrolled over a 14-year period were included in this study. Mild to severe
hyponatremia were defined as serum sodium concentration < 135, < 130, and < 125 mmol/L respectively. Mild to
severe hypernatremia were defined as serum sodium concentration > 145, > 150, and > 155 mmol/L respectively.
Borderline hyponatremia and hypernatremia were defined as serum sodium concentration between 135 and 137
mmol/L or 143 and 145 respectively.
Results: A total of 11,125 patients were included in this study. Among these patients, 3,047 (27.4%) had mild to
severe hyponatremia at ICU admission, 2,258 (20.3%) had borderline hyponatremia at ICU admission, 1,078 (9.7%)
had borderline hypernatremia and 877 (7.9%) had mild to severe hypernatremia. After adjustment for confounder,
both moderate and severe hyponatremia (subdistribution hazard ratio (sHR) 1.82, 95% CI 1.002 to 1.395 and 1.27,
95% CI 1.01 to 1.60 respectively) were associated with day-30 mortality. Similarly, mild, moderate and severe
hypernatremia (sHR 1.34, 95% CI 1.14 to 1.57; 1.51, 95% CI 1.15 to 1.99; and 2.64, 95% CI 2.00 to 3.81 respectively)
were independently associated with day-30 mortality.
Conclusions: One-third of critically ill patients had a mild to moderate dysnatremia at ICU admission. Dysnatremia,
including mild changes in serum sodium concentration, is an independent risk factor for hospital mortality and
should not be neglected.
Introduction
Dysnatremia is a common finding at ICU admission
[1-3]. Abnormal serum sodium concentrations are
known to adversely affect physiologic function and an
increasing body of evidence suggests that dysnatremia
may be associated with adverse outcome [1-4]. Critically
ill patients are particularly exposed to dysnatremia due
to the nature of the disease leading to ICU admission
and to lack of free access to water [2,4,5]. Up to one-
third of critically ill patients have a dysnatremia at ICU
admission [2]. In addition, another one-third of critically
ill patients will develop an ICU-acquired dysnatremia
during ICU stay [4,6]. Prevalence of dysnatremia at ICU
admission, however, varies greatly according to the cho-
sen definition [1,2,7,8].
Doubts exist regarding prognostic impact of borderline
changes in serum sodium concentration. Serum sodium
concentration is closely regulated and physiological
serum sodium concentration ranges between 138 and
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142 mmol per liter [9] whereas abnormal serum concen-
tration are usually defined as serum sodium lower than
135 or higher than 145 mmol per liter [2]. Most of the
studies performed to date chose to focus on severe dys-
natremia [1,5,7,10]. Recently, Funk and colleagues
demonstrated influence of dysnatremia at ICU admission
to be independently associated with outcome [2]. In this
study, mild dysnatremia was independently associated
with a poor outcome [2]. In addition, the association
between serum sodium concentration and prognosis fol-
lowed a U shape [2]. According to this observation, we
hypothesized that borderline and mild changes in serum
sodium concentration, lower than changes that usually
alert physicians, should be taken into account.
The objective of this study was to assess the preva-
lence of dysnatremia, including borderline changes in
serum sodium concentration in a large multicenter
cohort of patients and to confirm the association of
mild or moderate abnormal serum sodium concentra-
tion with mortality.
Materials and methods
Study design and data source
We conducted a retrospective study on a prospective
multicenter database (OutcomeRea™) to assess the epi-
demiological characteristics and prognostic impact of
dysnatremia. This study was approved by our institu-
tional review board (CECIC Clermont-Ferrand - IRB
number 5891; Ref: 2007-16) according to the French reg-
ulation on non-interventional studies which waived the
need for signed informed consent for patients included in
this database. Patients and patients’ next of kin were,
however, consulted for their willingness to decline parti-
cipation to this database, and none refused to participate.
The database, fed by 13 French ICUs, collects prospective
data on daily disease severity, iatrogenic events, and
nosocomial infections. Each year, each ICU includes a
random sample of at least 50 patients who have ICU
stays longer than 24 h. Each ICU could choose to obtain
the random sample by taking either consecutive admis-
sions to selected ICU beds throughout the year or conse-
cutive admissions to all ICU beds for 1 month.
Study population and definitions
We included consecutive patients who met the following
criteria: age older than 18 years, entry in the database
between January 1997 and April 2011. Patients without
serum sodium measurement at ICU admission or with
ICU stay of less than 48 h were secondarily excluded from
the study.
Serum sodium concentration is reported at ICU
admission.
We defined normal serum sodium concentration as a
serum sodium level between 138 and 142 mmol/L [9].
Borderline dysnatremia were defined as serum sodium
concentration between 135 and 137 mmol/L and
between 143 and 145 mmol/L for borderline hyponatre-
mia and for borderline hypernatremia respectively.
Hyponatremia were defined as serum sodium concen-
tration < 135 and ≥ 130, < 130 and ≥ 125 or < 125 for
mild, moderate and severe hyponatremia respectively [6].
Hypernatremia were defined as serum sodium concen-
tration > 145 and ≤ 150, > 150 and ≤ 155 or > 155 for
mild, moderate and severe hypernatremia respectively [6].
Data collection
Data were collected daily by senior physicians and/or
specifically trained study monitors in the participating
ICUs. For each patient, the investigators entered the data
into a computer case-report form using data-capture
software (RHEA; OutcomeRea™, France) and imported
all records into the OutcomeRea™ database. All codes
and definitions were established prior to study initiation.
The data quality checking procedure has been already
described elsewhere [11]. The following information was
recorded: age and sex, admission category (medical,
scheduled surgery, or unscheduled surgery), origin
(home, ward, or emergency department). Severity of ill-
ness was evaluated on the first ICU day using the Simpli-
fied Acute Physiology Score (SAPS) II, Sequential Organ
Failure Assessment (SOFA) score and the Logistic Organ
Dysfunction (LOD) score [12-14]. Knaus scale definitions
were used to record preexisting chronic organ failures
including respiratory, cardiac, hepatic, renal, and immune
system failure [15].
Quality of the database
For most of the study variables, the data-capture software
immediately ran an automatic check for internal consis-
tency, generating queries that were sent to the ICUs for
resolution before incorporation of the new data into the
database. In each participating ICU, data quality was
checked by having a senior physician from another parti-
cipating ICU review a 2% random sample of the study
data every other year. A 1-day data-capture training
course held once a year was open to all the Outco-
meRea™ investigators and study monitors. All qualitative
variables used in the analyses had  coefficients > 0.8 and
all variables had inter-rater coefficients in the 0.67 to 1
range, indicating good to excellent reproducibility.
Statistical analysis
Values of categorical variables are reported as numbers
(%) and values of continuous variables as medians (inter-
quartile range, IQR). The chi-square test was used for
categorical data and the Wilcoxon test for continuous data.
Potential risk factors for dysnatremia were entered in
a Fine and Gray extension of a Cox model. Then, we
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used the Fine and Gray subdistribution hazard regres-
sion model [16], with day-30 mortality as the variable of
interest. Discharge alive from the ICU was handled as a
competing event. Subdistribution hazard ratios (sHR)
and 95% confidence intervals (95% CI) were calculated.
P values < 0.05 were considered significant. Analyses




Of the 11,772 patients with ICU stays longer than 48 h
who were entered into the database during the study
period, 647 (5.5%) were excluded because of missing
data (Figure 1). A total of 11,125 patients were included
in this study. Some 3,047 (27.38%) had mild to severe
hyponatremia at ICU admission, 2,258 (20.30%) had
borderline hyponatremia at ICU admission, 1,078
(9.69%) had borderline hypernatremia and 877 (7.88%)
had mild to severe hypernatremia (Figure 1). Among
patients with mild to severe hyponatremia, 2,005
(18.02% of overall population) had mild hyponatremia,
693 (6.23% of overall population) had moderate hypona-
tremia, and 349 (3.14% of overall population) had severe
hyponatremia. Among patients with mild to severe
hypernatremia, 633 (5.69% of overall population) had
mild hypernatremia, 143 (1.29% of overall population)
had moderate hypernatremia, and 101 (0.91%) had
severe hypernatremia (Figure 1 and Additional file 1,
Figure S1). Serum sodium value at ICU admission is
reported in Figure 2.
Characteristics of patients
Characteristics of patients at ICU admission are
reported in Table 1. Overall, patients with dysnatremia
were older, less frequently of male gender, had a higher
body weight at ICU admission, a greater disease severity
as assessed by SAPS II, SOFA score, organ failure at
ICU admission or need for supportive therapy. In addi-
tion, patients with dysnatremia had more frequently
underlying chronic illnesses.
Outcome of patients with hypernatremia at ICU
admission
Before adjustment, mortality at day 30 was 21.0% in the
overall population of patients. Crude hospital mortality
was increased in patients with borderline to severe
hypernatremia and in patients with borderline to severe
hyponatremia (Figure 1 and 3). Day-30 mortality was of
16.6% in patients without dysnatremia at ICU admission,
19.0% in patients with borderline hyponatremia, 22.2%
in patients with mild hyponatremia, 26.4% in patients
with moderate hyponatremia and 23.8% in patients with
severe hyponatremia (Table 1 and Figure 3). Day-30
mortality was 22.5% in patients with borderline hyperna-
tremia, 32.1% in patients with mild hypernatremia,
39.9% in patients with moderate hypernatremia and
54.5% in patients with severe hypernatremia. Cumulated
Figure 1 Flow chart of patients admitted during the study period.
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incidence of mortality according to serum sodium con-
centration at ICU admission is reported in Additional
file 1, Figure S2a (hyponatremia) and Additional file 1,
Figure S2b (hypernatremia). Relationship between serum
sodium concentration and day-30 mortality is reported
in Additional file 1, Figure S3.
When entered into a Fine and Gray model (Table 2),
moderate to severe hyponatremia (sHR 1.82, 95% CI 1.002
to 1.395 and sHR 1.27, 95% CI 1.01 to 1.60 for moderate
and severe hyponatremia respectively) and mild to severe
hypernatremia (sHR 1.34, 95% CI 1.14 to 1.57; sHR 1.51,
95% CI 1.15 to 1.99; and sHR 2.64, 95% CI 2.00 to 3.81 for
mild, moderate and severe hypernatremia respectively)
remained independently associated with day-30 mortality.
Borderline hyponatremia (sHR 1.09, 95% CI 0.97 to 1.23; P
= 0.15) and borderline hypernatremia (sHR 1.14, 95% CI
0.99 to 1.33; P = 0.08) were not associated with day-30
mortality after adjustment for confounders. Figure 3
reports adjusted association between different class of
dysnatremia and day-30 mortality before and after
adjustment.
Discussion
This large multicenter cohort study, focusing specifically
on dysnatremia at ICU admission, demonstrates that
this electrolyte disorder is common and is an indepen-
dent risk factor for ICU mortality. This study confirms
that mild hypernatremia and moderate hyponatremia
(that is serum sodium concentration < 130 mmol/L or >
145 mmol/L respectively) are independently associated
with poor outcome.
In this study, one-third of critically ill patients had a
moderate to severe dysnatremia at ICU. Mild to severe
hypernatremia and hyponatremia were present in respec-
tively 7.8% and 27.4% of the admitted patients. Hypona-
tremia is the most common electrolyte disorder in
hospitalized patients. Up to 40% of the overall population
of hospitalized patients has a hyponatremia at admission
[17]. Presence of severe hyponatremia on hospital admis-
sion has been demonstrated to be independently asso-
ciated with an increased risk for ICU admission and poor
prognosis [18]. Hyponatremia may be due to chronic
organ dysfunctions (that is heart failure or liver dysfunc-
tion) but also to diuretic use, syndrome of inappropriate
antidiuretic hormone (ADH) secretion, adrenal insuffi-
ciency, and cerebral or renal salt wasting syndromes
[9,19]. Each of these conditions is frequently encountered
in critically ill patients and may explain the high preva-
lence of hyponatremia at ICU admission. Similarly,
although less frequent than hyponatremia, several studies
demonstrated hypernatremia to be common at ICU
admission [4-7]. Since thirst and free access to water are
the most important mechanisms that prevent hypernatre-
mia, critically ill patients and older patients are at high
risk for this disorder [4,19]. Only 2.5% patients have been
found to develop moderate to severe hypernatremia in
the general in-hospital population of patients. Higher
prevalence has been reported in geriatric or critically ill
patients [20-23].
In keeping with previous findings, our study demon-
strates a close association between dysnatremia and hospi-
tal mortality [1-3,8,13,24]. After adjustment for patients’
Figure 2 Natremia distribution at ICU admission.
Darmon et al. Critical Care 2013, 17:R12
http://ccforum.com/content/17/1/R12
Page 4 of 8






125 ≤ Na < 130
Mild hypoNa










142 > Na ≥ 145
Mild hyperNa










N = 349 N = 693 N = 2005 N = 2258 N = 3865 N = 1078 N = 633 N = 143 N = 101
Patient characteristics
Male gender 197 (56.4%) 392 (56.6%) 1211 (60.4%) 1381 (61.2%) 2391 (61.9%) 649 (60.2%) 380 (60%) 81 (56.6%) 60 (59.4%) 0.1846
Age (yrs) 62 (51-75) 63 (49.5-75.5) 63 (51-76) 62 (49-75) 63 (49-76) 62 (48-75) 65 (53-76) 67 (46-77) 64 (57-77) 0.0358
Weight (kg) 67 (56-80) 69 (58-81) 68 (58.4-80) 71 (60-83) 70.3 (60-83) 70 (60-82) 70 (59.7-81) 65 (59.7-80) 69 (55-80) < .0001
SOFA score [13] 6 (3-8) 6 (4-9) 5 (3-8) 5 (3-7) 5 (2-7) 5 (3-9) 7 (4-10) 8 (5-11) 8 (6-12) < .0001
SAPS II score [14] 56 (45-66) 57 (47-66) 55 (44-65) 51 (41-61) 50 (39-60) 53 (43-65) 57 (47-69) 63 (52-73) 66 (54-78) < .0001
Underlying condition
Chronic kidney disease 20 (5.7%) 50 (7.2%) 142 (7.1%) 121 (5.4%) 225 (5.8%) 61 (5.7%) 30 (4.7%) 7 (4.9%) 4 (4%) 0.2031
Immunocompromised 55 (15.8%) 143 (20.6%) 366 (18.3%) 343 (15.2%) 458 (11.8%) 128 (11.9%) 93 (14.7%) 12 (8.4%) 12 (11.9%) < .0001
Main symptom at admission
Acute respiratory
failure
65 (18.6%) 189 (27.3%) 529 (26.4%) 580 (25.7%) 893 (23.1%) 244 (22.6%) 151 (23.9%) 21 (14.7%) 20 (19.8%) 0.0003
Coma 68 (19.5%) 74 (10.7%) 216 (10.8%) 296 (13.1%) 661 (17.1%) 236 (21.9%) 138 (21.8%) 51 (35.7%) 28 (27.7%) < .0001
Septic shock 33 (9.5%) 98 (14.1%) 294 (14.7%) 225 (10%) 343 (8.9%) 107 (9.9%) 76 (12%) 18 (12.6%) 9 (8.9%) < .0001
Shock (other) 42 (12%) 86 (12.4%) 226 (11.3%) 218 (9.7%) 327 (8.5%) 122 (11.3%) 84 (13.3%) 16 (11.2%) 16 (15.8%) < .0001
Acute renal failure 47 (13.5%) 78 (11.3%) 128 (6.4%) 101 (4.5%) 108 (2.8%) 39 (3.6%) 25 (3.9%) 7 (4.9%) 7 (6.9%) < .0001
Trauma 0 1 (0.1%) 13 (0.6%) 19 (0.8%) 66 (1.7%) 11 (1%) 6 (0.9%) 5 (3.5%) 1 (1%) < .0001
Treatments at ICU admission
Antibiotics 190 (54.4%) 446 (64.4%) 1278 (63.7%) 1236 (54.7%) 1903 (49.2%) 567 (52.6%) 387 (61.1%) 90 (62.9%) 75 (74.3%) < .0001
Central venous
catheter
125 (35.8%) 312 (45%) 824 (41.1%) 867 (38.4%) 1446 (37.4%) 459 (42.6%) 342 (54%) 79 (55.2%) 60 (59.4%) < .0001
Vasoactive drugs 107 (30.7%) 259 (37.4%) 671 (33.5%) 650 (28.8%) 1041 (26.9%) 350 (32.5%) 277 (43.8%) 65 (45.5%) 49 (48.5%) < .0001
Mechanical ventilation 124 (35.5%) 253 (36.5%) 840 (41.9%) 1026 (45.4%) 1846 (47.8%) 605 (56.1%) 363 (57.3%) 93 (65%) 62 (61.4%) < .0001
Renal replacement
therapy
53 (15.2%) 113 (16.3%) 212 (10.6%) 217 (9.6%) 307 (7.9%) 96 (8.9%) 83 (13.1%) 11 (7.7%) 19 (18.8%) < .0001
Outcome
DFLST 16 (4.6%) 49 (7.1%) 108 (5.4%) 93 (4.1%) 171 (4.4%) 78 (7.2%) 51 (8.1%) 11 (7.7%) 7 (6.9%) < .0001
ICU mortality 66 (18.9%) 160 (23.1%) 381 (19%) 360 (15.9%) 551 (14.3%) 220 (20.4%) 176 (27.8%) 48 (33.6%) 49 (48.5%) < .0001
Day-30 mortality 83 (23.8%) 183 (26.4%) 446 (22.2%) 430 (19.0%) 642 (16.6%) 242 (22.5%) 203 (32.1%) 57 (39.9%) 55 (54.5%) < 0.001
Hospital mortality 89 (25.5%) 201 (29.0%) 483 (24.1%) 458 (20.3%) 693 (17.9%) 264 (24.5%) 215 (34.0%) 58 (40.6%) 57 (56.4%) < .0001
*Comparison across different subclasses of serum sodium concentration at ICU admission. The data are reported as medians (IQR). SOFA, Sequential Organ Failure Assessment, which can range from 0 to 24; SAPS II,














severity, increasing degree of dysnatremia was associated
with increasing prognostic impact. Interestingly, our study
demonstrates that mild to severe hypernatremia and mod-
erate to severe hyponatremia are independently associated
with outcome. Earlier studies reported an association
between dysnatremia and hospital mortality [1-3,10].
However, most of these studies evaluated the more severe
patients [1-3,10]. Recent studies suggested mild to moder-
ate changes in serum sodium concentration to be asso-
ciated with prognosis [2,24]. In our study, after adjustment
for comorbidities, case mix, or patients’ severity, even mild
hypernatremia and moderate hyponatremia were indepen-
dently associated with poor outcome. Hypernatremia has
multiple adverse effects that may explain this association.
Hypernatremia has been shown to be associated wit per-
ipheral insulin resistance, impaired hepatic lactate clear-
ance, decreased left ventricular contractility or various
neuromuscular manifestations ranging from muscle weak-
ness to delayed weaning from mechanical ventilation
[25-28]. Similarly, hyponatremia may be associated with
dismal neurological manifestations although occurring in
profound hyponatremia [9,19]. Our study, however, was
not designed to evaluate these consequences and no caus-
ality relationship can be drawn from this association. Last,
our study was unable to demonstrate an association
between outcome and borderline changes in natremia or
mild hyponatremia. Nevertheless, progressive association
between serum sodium changes and hospital mortality
suggest that we should pay attention to mild abnormal
serum sodium concentration.
Our study has several limitations. First, our study
design did not allow us to evaluate the causes of dysna-
tremia. No data regarding fluid balance or diuretic ther-
apy before ICU admission were available. In addition, as
previously stated, our study was not designed to evaluate
factors leading to this association. Although a causal role
for dysnatremia in death is biologically plausible, we can-
not determine from our data whether the association
between dysnatremia and mortality reflected a direct
effect of dysnatremia, a surrogate marker for underlying
comorbidities or reason for ICU admission, or both.
Further studies evaluating the influence of dysnatremia
Figure 3 Relationship between hospital admission serum sodium concentrations and day-30 mortality. Subdistribution hazard ratio (sHR)
and 95% confidence interval (95% CI) are represented before (light grey) and after adjustment for confounders (dark).
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correction on prognosis or the influence of therapeutic
intervention in patients with mild to moderate dysnatre-
mia may help in answering this clinical question.
Conclusions
Our results confirm the high prevalence of dysnatremia
at ICU admission and demonstrate that even mild to
moderate abnormal serum sodium concentrations are
independent risk factors for ICU mortality. Although we
must acknowledge that dysnatremia may be a surrogate
for patients’ severity, treatment or case mix, we believe
that mild abnormal serum sodium concentration should
not be neglected. Further studies are needed to under-
stand factors leading to this prognostic association and
the potential benefit from therapeutic strategies aiming
at this metabolic disturbance.
Key messages
• Dysnatremia is common at ICU admission. Mild to
severe hypernatremia and hyponatremia were present in
respectively 7.8% and 27.4% of the critically ill patients.
• Dysnatremia is independently associated with ICU
mortality. In our study, mild hypernatremia (that is
serum sodium concentration > 145 mmol/L) and mod-
erate hyponatremia (that is serum sodium concentration
< 130 mmol/L) are independently associated with poor
outcome (respective sHR of 1.34 (95% CI 1.14 to 1.57)
and 1.18 (95% CI 1.002 to 1.40)).
• Although a causal role for dysnatremia in death is
biologically plausible, we cannot determine from our
data whether the association between dysnatremia and
mortality reflected a direct effect of dysnatremia, a sur-
rogate marker for underlying comorbidities or reason
for ICU admission, or both.
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